prednisone has been researched along with Facio-Scapulo-Humeral Dystrophy in 1 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tacrolimus was treated to a goal serum trough of > 5 ng/mL and prednisone was tapered every month." | 1.62 | Adapting MRI as a clinical outcome measure for a facioscapulohumeral muscular dystrophy trial of prednisone and tacrolimus: case report. ( Bindschadler, M; Friedman, SD; Johnstone, LM; Tapscott, SJ; Wang, LH, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, LH | 1 |
| Johnstone, LM | 1 |
| Bindschadler, M | 1 |
| Tapscott, SJ | 1 |
| Friedman, SD | 1 |
1 other study available for prednisone and Facio-Scapulo-Humeral Dystrophy
| Article | Year |
|---|---|
Adapting MRI as a clinical outcome measure for a facioscapulohumeral muscular dystrophy trial of prednisone and tacrolimus: case report.
Topics: Humans; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Muscular Dystrophy, Faciosc | 2021 |